from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0728c/serA2

LFCtreatmentdescriptionclass of inhibitor

0.218

Amikacinug/mL Amikacintranslation

-0.324

Cap5-10ug/mL Capreomycintranslation

-0.106

Rox10-50 ug/mL Roxithromycintranslation

0.353

SM2-5 ug/mL Streptomycintranslation

-0.417

Tet5-10 ug/mL Tetracyclinetranslation

0.674

Rif0.2-5ug/mL Rifampicintranscription

0.161

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.201

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.893

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.474

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.877

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.629

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.290

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.255

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.878

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.598

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.359

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.492

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.342

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.059

KCN5-20 ug/mL Potassium cyaniderespiration

0.259

NaN30.2-2 mM Sodium aziderespiration

-0.178

Nigericin50 uM Nigericinrespiration

-0.465

TRC10-150 ug/mL Triclosanrespiration

-0.782

TRZ10-25 ug/mL Thioridazinerespiration

0.697

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.383

menadione6-10 ug/mL Menadionerespiration

0.858

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.069

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.330

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.952

NRP_1Non-replicating persistence stage 1dosRassociated

-0.283

Amp0.2mg/mL AmpicillincellWall

0.032

Cephalexin20-100 ug/mL CephalexincellWall

0.659

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.023

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.455

EMB10-20 ug/mL EthambutolcellWall

0.145

Eta12-40 ug/mL EthionamidecellWall

-0.134

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.009

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.757

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.161

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.461

BZA0.12 mg/mL BenzamidearomaticAmides

0.148

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.067

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.635

H2O24 mM hydrogen peroxideDNAdamaging

0.240

Levo10 ug/mL LevofloxacinDNAdamaging

0.773

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.092

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.172

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.986

UVUV-irradiationDNAdamaging

-1.021

ARP41-4 ug/mL Antitubercular compound ARP4?

0.043

Antimycin12.5-50 ug/mL Antimycin A?

-0.169

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.637

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.215

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.054

PA8240.2-2 ug/mL PA-824?

-0.020

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.156

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.251

Verapamil50 uM Verapamil?

-0.406

mercaptoethanol2 mM 2-Mercaptoethanol?

0.685

methoxatin10-20 ug/mL Methoxatin?